Testosterone valerate
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Trade names | Deposterona |
| Other names | Testosterone pentanoate; Testosterone 17β-valerate; Androst-4-en-17β-ol-3-one 17β-valerate |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.019.559 |
| Chemical and physical data | |
| Formula | C24H36O3 |
| Molar mass | 372.549 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Testosterone valerate, or testosterone pentanoate, also known as androst-4-en-17β-ol-3-one 17β-valerate, is a synthetic, steroidal androgen and an androgen ester – specifically, the C17β valerate ester of testosterone – which is used in veterinary medicine.[1] It is administered via intramuscular injection and acts as a long-lasting prodrug of testosterone.[1] The medication is available as a component of the veterinary drug Deposterona, which is marketed in Mexico and also contains testosterone acetate and testosterone undecanoate.[1] Testosterone valerate is a short-to-medium duration ester of testosterone, with an elimination half-life of approximately twice that of the short-acting testosterone propionate.[1]
See also
- Testosterone acetate/testosterone undecanoate/testosterone valerate
- Testosterone propionate/testosterone valerate/testosterone undecylenate
- List of androgen esters § Testosterone esters
References

